Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Person writing with pen

Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience.

Panayi MC. et al, (2022), Mol Psychiatry

Little evidence supports gabapentinoid use in bipolar disorder or insomnia

Saul H. et al, (2022), BMJ (Clinical research ed.), 379

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study.

Taquet M. et al, (2022), Neurology

CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology.

Harrison PJ. et al, (2022), Neuropharmacology

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.

Taquet M. et al, (2022), Lancet Psychiatry

New drug targets in psychiatry: Neurobiological considerations in the genomics era.

Harrison PJ. et al, (2022), Neurosci Biobehav Rev, 139

Response to the letter by Lin et al.

Taquet M. et al, (2022), Brain Behav Immun, 104

Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic Review.

Zangani C. et al, (2022), JMIR Ment Health

Using a generative model of affect to characterize affective variability and its response to treatment in bipolar disorder.

Pulcu E. et al, (2022), Proc Natl Acad Sci U S A, 119

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.

Taquet M. et al, (2022), Brain Behav Immun, 103, 154 - 162

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Au-Yeung SK. et al, (2022), Evid Based Ment Health, 25, 77 - 83

Restricting the spread of SARS-CoV-2 or safeguarding mental health: a false dichotomy?

Taquet M. and Harrison PJ., (2022), Lancet Public Health, 7, e392 - e393

Catechol-O-methyltransferase activity does not influence emotional processing in men.

Martens MA. et al, (2022), J Psychopharmacol

Impact of the COVID-19 pandemic on the global delivery of mental health services and tele-mental health: a systematic review (Preprint)

Zangani C. et al, (2022), JMIR Mental Health

Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.

Al-Diwani A. et al, (2022), Brain

Association between serum lithium level and incidence of COVID-19 infection.

De Picker LJ. et al, (2022), Br J Psychiatry, 1 - 3

Accurate expression quantification from nanopore direct RNA sequencing with NanoCount.

Gleeson J. et al, (2022), Nucleic Acids Res, 50

Characterizing Affective Variability in Bipolar Disorder and Borderline Personality Disorder, and the Effects of Lithium, Using a Generative Model of Affect

Pulcu E. et al, (2022)

Exposure to phenytoin associates with a lower risk of post-COVID cognitive deficits: a cohort study.

Taquet M. and Harrison PJ., (2022), Brain Commun, 4

Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues.

Ang G. et al, (2021), Transl Psychiatry, 11

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?